Dr. Umedjon Ibragimov combines his programmatic expertise and academic scholarship to advance the health of people who use drugs and other populations disproportionately affected by HIV. He applies rigorous quantitative and qualitative methods and community-based participatory research methods to study stigma and other social and structural determinants of drug- and HIV-related outcomes and utilizes implementation science approaches to improve access to HIV and drug-related services in the US and globally. He received his MD degree from Tajik State Medical University (1999), and Master of Public Health (2009) and PhD (2017) degrees from Emory University.  

Dr. Ibragimov’s past work focused on exploring the role of such structural determinants as structural racism and economic policies in epidemics of HIV and sexually transmitted infections in large US metropolitan areas.  He also studied HIV prevention interventions among people who inject drugs in Eastern Europe and Central Asia, explored the role of stigma and violence as barriers to services among men who have sex men (MSM) in Tajikistan and advanced methodology of HIV and substance use research among MSM in China. His current projects involve addressing barriers to implementation of syringe service programs for people who inject drugs and peer-led interventions for emergency department patients with substance use disorders in the US.